Nanwei Xu
机构：Sichuan University, West China Hospital of Sichuan University, Changzhou No.2 People's Hospital, Changzhou Third People's Hospital
发表论文 41 篇 · 总被引 164 次 · h-index 5
代表论文
- Prognostic significance of circulating tumor DNA in urothelial carcinoma: a systematic review and meta-analysis (2024 · International Journal of Surgery · 被引 17)
- Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targets (2025 · Nature Communications · 被引 14)
- First-line systemic therapy in patients with metastatic or locally advanced urothelial carcinoma: a systematic review and network meta-analysis of randomized controlled trials (2025 · Therapeutic Advances in Medical Oncology · 被引 4)
- Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker of proliferation Ki67 (2024 · The Prostate · 被引 4)
- Pretreatment intratumoral mature TLSs in non-clear cell renal cell carcinoma are associated with response to immunotherapy rechallenge (2026 · Journal for ImmunoTherapy of Cancer)
- Bilateral versus Unilateral Decompression in Single-Level Transforaminal Lumbar Interbody Fusion for Degenerative Spondylolisthesis: A Retrospective Comparative Study (2026 · World Neurosurgery)